Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Aveo Pharmaceuticals closes IPO and nets $83.4mm

Executive Summary

Cancer therapy developer Aveo Pharmaceuticals completed its initial public offering, netting $83.4mm through the sale of 9.97mm common shares (including the exercise of 969k of the 1.35mm shares marked for the overallotment) at $9 each. The company initially filed in December 2009, and last month announced its intention to sell 7mm shares priced between $13-15.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Pharmacogenetics-Pharmacogenomics
    • Large Molecule
      • Antibodies
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies